Charlotte Guldborg Nyvold is a Professor at the University of Southern Denmark. Her clinical interests are Lymphoma, Flow Cytometry, Hematological Malignancies, Hematologic Diseases, Myelodysplastic Syndromes, Clinical Hematology, Hematopoietic Stem Cell Transplantation, Bone Marrow Transplantation, and Blood Disorders. She has an h-Index of 20 and her papers have been cited more than 1100 times (Scopus, 30 October 2023).
Thomas Levin Andersen is an Associate Professor at the Department of Clinical Research, University of Southern Denmark; the Department of Pathology, Odense University Hospital; and the Department of Forensic Medicine, Aarhus University in Denmark. He received his M.Sc. in 2001 from Copenhagen University in Biochemistry and Molecular Biology and his Ph.D. in 2013 from Aarhus University in Health. He teaches bone physiology and pathophysiology as well as molecular histology and morphometry. He currently serves as president of the International Society of Bone Morphometry (ISBM) and founding president of the Danish Bone Research Workshop. His Molecular Bone Histology team currently includes 12 technicians, students, and postdocs and an extended network of clinical, interdisciplinary, and international collaborators. His main focus is human bone remodeling under physiological and pathophysiological conditions, including aging, osteoporosis, diabetes, myeloma, bone metastasis, and rare genetic bone disease.
Niels Abildgaard is a Professor and Head of Hematology Research at the University of Southern Denmark in Odense, Syddanmark, Denmark. He obtained his MD degree from the University of Aarhus, Denmark, in 1983 and received authorization to practice medicine in Denmark in 1985. From 1983 to 1991, he served as a Resident and Senior House Officer at Aarhus University Hospital and Aalborg Hospital, Denmark. He was a Senior Registrar at the Department of Hematology, Aarhus University Hospital, from 1997 to 2002, and then at the Department of Hematology, Rigshospitalet, Copenhagen, Denmark. Since 2004, he has been working as Chief Consultant and Head of Research at the Department of Hematology, Odense University Hospital, Denmark. His research focuses on multiple myeloma (bone marrow cancer), including all aspects from disease biology to treatment, with a particular emphasis on bone disease associated with multiple myeloma.
Thomas Lund is Chief Physician at the Department of
Hematology, Odense University Hospital, Denmark. He was appointed Associate
Professor at the University of Southern Denmark in 2015. He received his Ph.D.
in Bone Disease in Multiple Myeloma in 2010 and has published several
peer-reviewed articles on this subject. He has an h-Index of 9 and his papers
have been cited more than 360 times (Scopus, 27 October 2023).
